NCT03063697View on ClinicalTrials.gov

Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart Failure

UnknownOBSERVATIONAL
Enrollment

20,000

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Essential HypertensionChronic Stable AnginaCongestive Heart Failure
Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT03063697 - Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart Failure | Biotech Hunter | Biotech Hunter